Predictions
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.24
01.02.21
01.02.21
€40.00
01.02.22
01.02.22
1.56%
01.02.22
01.02.22
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.17
01.02.21
01.02.21
€26.00
30.06.22
30.06.22
-10.17%
19.05.22
19.05.22
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€222.00
01.02.21
01.02.21
€260.00
30.03.22
30.03.22
-6.17%
09.10.21
09.10.21
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€6.91
29.01.21
29.01.21
€8.00
16.27%
06.02.21
06.02.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€37.03
29.01.21
29.01.21
€34.00
29.04.21
29.04.21
-5.94%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Inovio Pharma
Start price
Target price
Perf. (%)
€9.50
28.01.21
28.01.21
€14.00
23.16%
04.02.21
04.02.21
Risky Investment
High risks for its business
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€38.44
27.01.21
27.01.21
€45.00
27.01.22
27.01.22
-4.29%
28.01.22
28.01.22
Could be worthwhile Investment >10% per year
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€240.00
25.01.21
25.01.21
€350.00
25.01.22
25.01.22
-73.33%
26.01.22
26.01.22
Could be very worthwhile Investment >20% year
Visiomed Group
Start price
Target price
Perf. (%)
€0.86
25.01.21
25.01.21
€1.00
25.01.22
25.01.22
-80.01%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€173.98
25.01.21
25.01.21
€250.00
25.01.22
25.01.22
23.00%
17.01.22
17.01.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€22.08
25.01.21
25.01.21
€35.00
30.39%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€2.10
25.01.21
25.01.21
€3.00
25.01.22
25.01.22
63.56%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€36.75
25.01.21
25.01.21
€50.00
25.01.22
25.01.22
-12.24%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€7.55
25.01.21
25.01.21
€10.00
25.01.22
25.01.22
-2.65%
08.02.21
08.02.21
Could be very worthwhile Investment >20% year
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€63.50
24.01.21
24.01.21
-
24.01.22
24.01.22
-15.72%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€1.85
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-41.51%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.16
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-67.09%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.36
23.01.21
23.01.21
€100.00
23.01.22
23.01.22
-77.10%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Advaxis Inc.
Start price
Target price
Perf. (%)
€0.62
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-81.94%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Arca Biopharma
Start price
Target price
Perf. (%)
€3.98
23.01.21
23.01.21
€30.00
23.01.22
23.01.22
-60.05%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year